328 related articles for article (PubMed ID: 33892690)
1. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma.
Saleem Z; Shaikh AH; Zaman U; Ahmed S; Majeed MM; Kazmi A; Farooqui WA
BMC Oral Health; 2021 Apr; 21(1):205. PubMed ID: 33892690
[TBL] [Abstract][Full Text] [Related]
2. Relation of salivary MMP-8 with oral submucous fibrosis and oral squamous cell carcinoma: a cross sectional analytical study.
Kazmi A; Abbas Z; Saleem Z; Haider S; Farooqui WA; Ahmed S
BMJ Open; 2022 Dec; 12(12):e060738. PubMed ID: 36523229
[TBL] [Abstract][Full Text] [Related]
3. Analytical Study Of Salivary Mmp-12 Expression In Oral Submucous Fibrosis.
Saleem Z; Shaikh AH; Majeed MM; Ahmed S; Zaman U; Siddiqui Z; Kazmi A
J Ayub Med Coll Abbottabad; 2022; 34(2):247-250. PubMed ID: 35576280
[TBL] [Abstract][Full Text] [Related]
4. Carcinogenesis of Male Oral Submucous Fibrosis Alters Salivary Microbiomes.
Chen MY; Chen JW; Wu LW; Huang KC; Chen JY; Wu WS; Chiang WF; Shih CJ; Tsai KN; Hsieh WT; Ho YH; Wong TY; Wu JH; Chen YL
J Dent Res; 2021 Apr; 100(4):397-405. PubMed ID: 33089709
[TBL] [Abstract][Full Text] [Related]
5. Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis-Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment.
Zhi Y; Wang Q; Zi M; Zhang S; Ge J; Liu K; Lu L; Fan C; Yan Q; Shi L; Chen P; Fan S; Liao Q; Guo C; Wang F; Gong Z; Xiong W; Zeng Z
Adv Sci (Weinh); 2024 Mar; 11(12):e2306515. PubMed ID: 38229179
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of oral squamous cell carcinoma with oral submucous fibrosis.
Saalim M; Sansare K; Karjodkar FR; Johaley S; Ali IK; Sharma SR; Mehra A; Rahman B
J Cancer Res Ther; 2021; 17(6):1510-1514. PubMed ID: 34916386
[TBL] [Abstract][Full Text] [Related]
7. Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis.
Choudhari S; Masne S; Bhandare P; Dhumal S
J Cancer Res Ther; 2022; 18(1):55-65. PubMed ID: 35381762
[TBL] [Abstract][Full Text] [Related]
8. Study on the expression and function of smad family member 7 in oral submucous fibrosis and oral squamous cell carcinoma.
Hu X; Xiong H; Wang W; Huang L; Mao T; Yang L; Wang C; Huang D; Wu J; Xia K; Su T
Arch Oral Biol; 2020 Apr; 112():104687. PubMed ID: 32114253
[TBL] [Abstract][Full Text] [Related]
9. Change and pathological significance of glycogen content in oral squamous cell carcinoma and oral submucous fibrosis.
Nie H; Hu X; Xiong H; Zeng L; Chen W; Su T
Tissue Cell; 2024 Apr; 87():102337. PubMed ID: 38430849
[TBL] [Abstract][Full Text] [Related]
10. Skewed Th17/Treg balance during progression and malignant transformation of oral submucous fibrosis.
Liu S; Liu Z; Shan Z; Liu Y; Chen T; Fang L; Quan H
Oral Dis; 2022 Nov; 28(8):2119-2130. PubMed ID: 33749974
[TBL] [Abstract][Full Text] [Related]
11. Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma.
Li Z; Fu Y; Hu Y; Zhu Y; Hu L; Shi C; Zhang Y; Zhang J; Zhou S
BMC Oral Health; 2023 Mar; 23(1):171. PubMed ID: 36966276
[TBL] [Abstract][Full Text] [Related]
12. IRF4 as a novel target involved in malignant transformation of oral submucous fibrosis into oral squamous cell carcinoma.
Meng L; Jiang Y; You J; Zhao P; Liu W; Zhao N; Yu Z; Ma J
Sci Rep; 2023 Feb; 13(1):2775. PubMed ID: 36797470
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of programmed death-1 and its ligand, programmed death ligand-1 in oral squamous cell carcinoma with and without oral submucous fibrosis.
Quan H; Liu S; Shan Z; Liu Z; Chen T; Hu Y; Yao Z; Fang L
Arch Oral Biol; 2020 Nov; 119():104916. PubMed ID: 32977151
[TBL] [Abstract][Full Text] [Related]
14. Ki67, CD105, and α-SMA Expression Supports Biological Distinctness of Oral Squamous Cell Carcinoma Arising in the Background of Oral Submucous Fibrosis.
Gadbail AR; Korde S; Chaudhary MS; Sarode SC; Gondivkar SM; Dande R; Tekade SA; Yuwanati M; Hande A; Patil S
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2067-2074. PubMed ID: 32711434
[TBL] [Abstract][Full Text] [Related]
15. Clinical validation of a saliva-based matrix metalloproteinase-1 rapid strip test for detection of oral cavity cancer.
Chu LJ; Chang YT; Chien CY; Chung HC; Wu SF; Chen CJ; Liu YC; Liao WC; Chen CH; Chiang WF; Chang KP; Wang JS; Yu JS
Biomed J; 2024 Feb; 47(1):100594. PubMed ID: 37044249
[TBL] [Abstract][Full Text] [Related]
16. Gene mutation analysis of oral submucous fibrosis cancerization in Hainan Island.
Li B; Chen X; Xian H; Wen Q; Wang T
PeerJ; 2023; 11():e16392. PubMed ID: 38050610
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases-3 gene-promoter polymorphism as a risk factor in oral submucous fibrosis in an Indian population: a pilot study.
Zade PR; Gosavi SR; Hazarey VK; Ganvir SM
J Investig Clin Dent; 2017 Aug; 8(3):. PubMed ID: 27389714
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
19. Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions.
Ghallab NA; Shaker OG
Clin Oral Investig; 2017 Apr; 21(3):937-947. PubMed ID: 27161218
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of salivary MMP-9 in oral squamous cell carcinoma and oral leukoplakia using ELISA.
Pazhani J; Chanthu K; Jayaraman S; Varun BR
J Oral Maxillofac Pathol; 2023; 27(4):649-654. PubMed ID: 38304520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
